APA (7th ed.) Citation

RJ, S., AJ, S., CR, D., S, H., H, P., G, J., . . . Y, S. (2023). An open-label, proof-of-concept study assessing the effects of bromelain-based enzymatic debridement on biofilm and microbial loads in patients with venous leg ulcers and diabetic foot ulcers. Wounds : a compendium of clinical research and practice, 35(12), E414. https://doi.org/10.25270/wnds/23099

Chicago Style (17th ed.) Citation

RJ, Snyder, et al. "An Open-label, Proof-of-concept Study Assessing the Effects of Bromelain-based Enzymatic Debridement on Biofilm and Microbial Loads in Patients with Venous Leg Ulcers and Diabetic Foot Ulcers." Wounds : A Compendium of Clinical Research and Practice 35, no. 12 (2023): E414. https://doi.org/10.25270/wnds/23099.

MLA (9th ed.) Citation

RJ, Snyder, et al. "An Open-label, Proof-of-concept Study Assessing the Effects of Bromelain-based Enzymatic Debridement on Biofilm and Microbial Loads in Patients with Venous Leg Ulcers and Diabetic Foot Ulcers." Wounds : A Compendium of Clinical Research and Practice, vol. 35, no. 12, 2023, p. E414, https://doi.org/10.25270/wnds/23099.